Ningbo NO.1 hospital
Ningbo, Zhejiang, 315010, China
NCT Number: NCT03482921
This study is to assess the predictive significance of visceral adipose tissue (VAT) and visceral adipose tissue /skeletal muscle tissue ratio (VAT/SMT ratio) for the prognosis in acute pancreatitis (AP) patients.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Observational
Ningbo, Zhejiang, 315010, China
Acute pancreatitis (AP) is a sudden inflammation of the pancreas. However, one-fifth of patients may develop severe complications with a mortality between 10%-20% It remains a difficulty to find an effective method for prediction of severity of AP at early stage.
It is well-established that obesity (defined as body mass index[BMI]>30kg/m2 by the World Health Organization) is a risk factor for AP and increases the incidence of systemic complication, motality. There are a lot of parameters related to saropenic obesity, including areas of visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), skeletal muscle tissue (SMT), and VAT/SMT ratio. it is unclear which parameter is the best predictor of severe AP. Thus, this study is aimed to investigate the association between these parameters and AP severity and find the best predictor of AP.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: the physical examination data in the year of 2017
Comparisons of variables according to AP severity by one-way analysis of variance (ANOVA) and Likelihood Ratio
Time frame: the physical examination data in the year of 2017
Relationships between VAT and severity outcomes by Likelihood Ratio
Ningbo No. 1 Hospital
Other
Body Parameters as an Independent Predictor of Acute Pancreatitis: A Propensity Score-matched Case-control Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07712081
Acute Pancreatitis, Digestive System Diseases
Rui’an, Zhejiang, China
View Trial DetailsNCT05651360
Abdominal Pain, Acute Appendicitis
Odense, Denmark
View Trial DetailsNCT05201053
Acute Pancreatitis, Digestive System Diseases
Malmö, Skåne County, Sweden
View Trial DetailsNCT03401190
Acute Pancreatitis, Digestive System Diseases
Detroit, Michigan, United States
View Trial Details